FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2763871013> ?p ?o ?g. }

• W2763871013 endingPage "95029" @default.
• W2763871013 startingPage "95023" @default.
• W2763871013 abstract "// Shi-Long Zhang 1 , Li Liang 2 , Yuan Ji 3 , Zhi-Ming Wang 2 and Yu-Hong Zhou 2 1 Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China 2 Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China 3 Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China Correspondence to: Yu-Hong Zhou, email: // Zhi-Ming Wang, email: // Keywords : recurrence/metastatic epithelioid angiosarcoma; everolimus; targeted therapy Received : August 15, 2017 Accepted : September 25, 2017 Published : October 15, 2017 Abstract Epithelioid angiosarcoma (EA) is a kind of rare malignant soft tissue sarcoma, with high recurrence/metastatic rate and poor prognosis. To date, no effective standardized treatment regimen has been available for patients with recurrence/metastatic EA. Everolimus is an oral rapamycin derivative that highly inhibits the mechanistic target of rapamycin(mTOR) signal pathway. Previous studies have suggested that everolimus is effective and safe in some soft tissue sarcoma. We reported two cases with recurrence/metastatic EA, who received everolimus after failure of surgery, radiotherapy, chemotherapy or interventional therapy. Two cases obtained clinical benefit within 1 week, and were evaluated as partial response (PR). The progression free survival (PFS) time was nearly 12.0 and 6.0 months, respectively. The overall survival (OS) time was 18.0 and 10.0 months, respectively. The main adverse event was stomatitis syndrome (grade 1-2), which was well controllable and tolerable. It indicated that everolimus may be more beneficial for recurrence/metastatic EA patients." @default.
• W2763871013 created "2017-10-20" @default.
• W2763871013 creator A5012868175 @default.
• W2763871013 creator A5021622922 @default.
• W2763871013 creator A5034093082 @default.
• W2763871013 creator A5064161818 @default.
• W2763871013 creator A5089515440 @default.
• W2763871013 date "2017-10-15" @default.
• W2763871013 modified "2023-09-27" @default.
• W2763871013 title "The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review" @default.
• W2763871013 cites W1199512068 @default.
• W2763871013 cites W121459652 @default.
• W2763871013 cites W1970637515 @default.
• W2763871013 cites W1977440212 @default.
• W2763871013 cites W1985934694 @default.
• W2763871013 cites W1992253423 @default.
• W2763871013 cites W2004088008 @default.
• W2763871013 cites W2012909164 @default.
• W2763871013 cites W2025935112 @default.
• W2763871013 cites W2041944081 @default.
• W2763871013 cites W2055359615 @default.
• W2763871013 cites W2071323844 @default.
• W2763871013 cites W2078720352 @default.
• W2763871013 cites W2084097683 @default.
• W2763871013 cites W2094532843 @default.
• W2763871013 cites W2115686439 @default.
• W2763871013 cites W2118677643 @default.
• W2763871013 cites W2132428290 @default.
• W2763871013 cites W2143393758 @default.
• W2763871013 cites W2149218373 @default.
• W2763871013 cites W2151082560 @default.
• W2763871013 cites W2168298851 @default.
• W2763871013 cites W2171144156 @default.
• W2763871013 cites W2172010863 @default.
• W2763871013 cites W2209368665 @default.
• W2763871013 cites W2278915231 @default.
• W2763871013 cites W2560670949 @default.
• W2763871013 cites W2622342764 @default.
• W2763871013 cites W2765719727 @default.
• W2763871013 cites W3148414456 @default.
• W2763871013 cites W4241497580 @default.
• W2763871013 doi "https://doi.org/10.18632/oncotarget.21832" @default.
• W2763871013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5706933" @default.
• W2763871013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29212287" @default.
• W2763871013 hasPublicationYear "2017" @default.
• W2763871013 type Work @default.
• W2763871013 sameAs 2763871013 @default.
• W2763871013 citedByCount "8" @default.
• W2763871013 countsByYear W27638710132018 @default.
• W2763871013 countsByYear W27638710132019 @default.
• W2763871013 countsByYear W27638710132021 @default.
• W2763871013 countsByYear W27638710132022 @default.
• W2763871013 crossrefType "journal-article" @default.
• W2763871013 hasAuthorship W2763871013A5012868175 @default.
• W2763871013 hasAuthorship W2763871013A5021622922 @default.
• W2763871013 hasAuthorship W2763871013A5034093082 @default.
• W2763871013 hasAuthorship W2763871013A5064161818 @default.
• W2763871013 hasAuthorship W2763871013A5089515440 @default.
• W2763871013 hasBestOaLocation W27638710131 @default.
• W2763871013 hasConcept C126322002 @default.
• W2763871013 hasConcept C141071460 @default.
• W2763871013 hasConcept C142724271 @default.
• W2763871013 hasConcept C143998085 @default.
• W2763871013 hasConcept C204232928 @default.
• W2763871013 hasConcept C2776694085 @default.
• W2763871013 hasConcept C2778256501 @default.
• W2763871013 hasConcept C2778629024 @default.
• W2763871013 hasConcept C2779217266 @default.
• W2763871013 hasConcept C2779699572 @default.
• W2763871013 hasConcept C2780739268 @default.
• W2763871013 hasConcept C2781113665 @default.
• W2763871013 hasConcept C2781413609 @default.
• W2763871013 hasConcept C71924100 @default.
• W2763871013 hasConceptScore W2763871013C126322002 @default.
• W2763871013 hasConceptScore W2763871013C141071460 @default.
• W2763871013 hasConceptScore W2763871013C142724271 @default.
• W2763871013 hasConceptScore W2763871013C143998085 @default.
• W2763871013 hasConceptScore W2763871013C204232928 @default.
• W2763871013 hasConceptScore W2763871013C2776694085 @default.
• W2763871013 hasConceptScore W2763871013C2778256501 @default.
• W2763871013 hasConceptScore W2763871013C2778629024 @default.
• W2763871013 hasConceptScore W2763871013C2779217266 @default.
• W2763871013 hasConceptScore W2763871013C2779699572 @default.
• W2763871013 hasConceptScore W2763871013C2780739268 @default.
• W2763871013 hasConceptScore W2763871013C2781113665 @default.
• W2763871013 hasConceptScore W2763871013C2781413609 @default.
• W2763871013 hasConceptScore W2763871013C71924100 @default.
• W2763871013 hasIssue "55" @default.
• W2763871013 hasLocation W27638710131 @default.
• W2763871013 hasLocation W27638710132 @default.
• W2763871013 hasLocation W27638710133 @default.
• W2763871013 hasLocation W27638710134 @default.
• W2763871013 hasOpenAccess W2763871013 @default.
• W2763871013 hasPrimaryLocation W27638710131 @default.
• W2763871013 hasRelatedWork W1936216083 @default.
• W2763871013 hasRelatedWork W1979768828 @default.
• W2763871013 hasRelatedWork W2036109712 @default.
• W2763871013 hasRelatedWork W2387456186 @default.

• next